11Mon·

Good morning everyone,

I am looking for a share in the pharmaceutical/healthcare sector. The classic J+J is in my portfolio. I would actually like to add a similar classic. But my knowledge of the sector is a bit thin on the ground.

My requirements (in descending order of importance):

Market cap > 10 bn.

P/E ratio < 30 (better <20)

Dividende: ja, bestenfalls > 2.5%)


The stock finder then basically only spits out $MRK (+0.11%) out.

Am I missing something? I don't want to simply buy J+J and only have these in the pharma sector.


Pfizer? Bayer? Both would be turnaround bets that are out of the question for me right now.

$AZN (+0.02%) my gut feeling is a bit worried about (honestly: because of the corona vaccine😄)

3
24 Comments

profile image
What about $BMY? P/E ratio approx. 13, dividend yield >4.5%, market cap well over 10MRD.
6
profile image
For me, only J+J, Novo Nordisk (currently very expensive) and Biontech for risk takers are interesting in this area
1
profile image
@Finanzinho ah yes, I forgot Novo in the list. That's exactly how I see it.
Thank you
profile image
I still have amgen and abbvie in my portfolio. They are more biotech but very solid and pay a nice dividend. However, they have also performed well again recently.
1
Deleted User
11Mon
Comment was deleted
profile image
profile image
Amgen $AMGN as the largest biotech company
Thermo Fisher $TMO as laboratory supplier among others
Stryker $SYK with a focus on medical technology
1
profile image
$NOVO B $WST $AFX $VRTX $TMO $DHR $ICLR. They are all top companies. You can then look for yourself according to your criteria😉. I wouldn't get too hung up on the P/E ratio for good shares.
profile image
$ABBV yes, P/E higher, but nice mix of share price and divi
profile image
profile image
Don't look at the P/E ratio, look at the PEG
profile image
@Ayecaramba256 Yes, I regularly include that in my analysis.
However, it did yesterday with the pharma companies: P/E below 30/ PEG below 1.5, then filtered out all companies 😂
If you look at the industry average, P/E ratio 30 is actually something that shouldn't filter too much. Except maybe the dietary supplement companies 👀
profile image
@Specter Do you want to buy once or in tranches? If a one-time purchase, I would take Abbvie or Merck & Co. For tranches probably Novo Nordirsk or Elli Lilly (both are a bit inflated)
profile image
@Ayecaramba256 rather a one-time purchase... AbbVie has just become my favorite 😬
profile image
I wouldn't look at the dividend yield if you're reinvesting it anyway.

I personally have Danaher and Eli Lilly in my portfolio in addition to J&J.
profile image
$NOVN and $REC came to mind spontaneously.
profile image
$LLY but also very expensive and constantly at an all-time high. today there will also be figures.
but you can put it on your watchlist :)
profile image
@1Chrischi1 yes, I actually had them in mind too... PEG is <1 for 2023 according to onvista. So maybe not that expensive 👀
profile image
i meant expensive in the sense of buying. i bought about 2 weeks ago and since then it's been going up every day 💪
I think the figures at 14:30 will also be good 🚀🚀🚀
profile image
profile image
$DVA I find it very interesting, but I don't think they pay a dividend (yet)
profile image
$GSK $PFE $BMY meet your criteria and are interesting.
profile image
$BMY TOP value in my opinion 💪💪
The market may have punished the company too harshly
profile image
I joined $CVS and am convinced by them in the long term.
Join the conversation